BPH Global Ltd (ASX:BP8)

Australia · Delayed Price · Currency is AUD

0.0010

0.00 (0.00%)

Sep 7, 2026, 9:59 AM AEST

Market Cap	2.35M +12.0%
Revenue (ttm)	3.44M +877.5%
Net Income	-1.79M
EPS	-0.00
Shares Out	2.35B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40
Open	0.0010
Previous Close	0.0010
Day's Range	0.0010 - 0.0010
52-Week Range	0.0010 - 0.0030
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About BPH Global

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. BPH Global Ltd was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. The co... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1984

Employees 31

Stock Exchange Australian Securities Exchange

Ticker Symbol BP8

Full Company Profile

Financial Performance

In fiscal year 2026, BPH Global's revenue was 3.44 million, an increase of 877.51% compared to the previous year's 352,376. Losses were -1.79 million, 20.3% more than in 2025.

Financial Statements